Therapeutic and diagnostic agents

Details Therapeutic and diagnostic agents Therapeutic and diagnostic agents

2007-10-09

2007-10-09

Carlson, Karen Cochrane (Department: 1656)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C536S023100

Reexamination Certificate

active

10991181

ABSTRACT:
The present invention relates generally to therapeutic and diagnostic agents. More particularly, the present invention provides therapeutic molecules capable of modulating signal transduction such as but not limited to cytokine-mediated signal transduction. The molecules of the present invention are useful, therefore, in modulating cellular responsiveness to cytokines as well as other mediators of signal transduction such as endogenous or exogenous molecules, antigens, microbes and microbial products, viruses or components thereof, ions, hormones and parasites.

REFERENCES:
patent: 5871960 (1999-02-01), Smith et al.
patent: 6323317 (2001-11-01), Hilton et al.
patent: 0 989 186 (2000-03-01), None
patent: 94/28156 (1994-12-01), None
patent: WO98/30688 (1998-07-01), None
patent: WO99/03993 (1999-01-01), None
Yoshimura et al. 1995; A novel cytokine inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14 (12): 2816-2826.
Mashura et al. Oct. 1997; Cloning and characterization of novel CIS family genes. Biochem. Biophys. Res. Commun. 239: 439-446.
Accession No. Z4752, ID:MMPRMGNS (1995), XDP-002165867 (Abstract).
Schluter, G. et al., “Sequence Analysis of the Conserved Protamine Gene Cluster Shows That it Contains a Fourth Expressed Gene”,Molecular Reproduction and Development 43:1-6 (1996), XP-000993037.
Accession No. Z46940; ID: HSPRMTNP2 (1995), XP-002165868 (Abstract).
Accession No. Z46939; ID: BTPRMTNP2 (1995) (Abstract).
Yoshimura, A. et al., “A Novel Cytokine-Inducible Gene CIS Encodes an SH2-Containg Protein that Binds to Tyrosine-Phosphorylated Interleukin 3 and Erythropoietin Receptors”,The EMBO Journal 14(12):2816-2826 (1995), XP-002088456.
Minamoto, S. et al., “Cloning and Functional Analysis of New Members of STAT Induced STAT Inhibitor (SSI) Family: SSI-2 and SSI-3”,Biochemical and Biophysical Research Communications 237:79-83 (1997), XP-002095406.
Accession No. U72673, ID: MMU72673 (1997), XP-002172403 (Abstract).
Fu, X., et al., “E2a-Pbx1 Induces Aberrant Expression of Tissue-Specific and Developmentally Regulated Genes When Expressed in NIH 3T3 Fibroblasts”,Molecular and Cellular Biology 17(3): 1503-1512 (1997), XP-002172402.
Starr, R. et al., “A Family of Cytokine-Inducible Inhibitors of Signalling”,Nature 387: 917-921 (1997), XP-002085491.
Endo, T.A. et al., “A New Protein Containing an SH2 Domain that Inhibits JAK Kinases”,Nature 387: 921-924 (1997), XP-002085492.
Naka, T. et al., “Structure and Function of a New STAT-Induced STAT Inhibitor”,Nature 387: 924-928 (1997), XP-002088455.
Accession No. AA189608, ID: MMAA81160 (1997), XP-002172404 (Abstract).
Hilton, D.J. et al., “Twenty Proteins Containing a C-Terminal SOCS Box Form Five Structural Classes”,Proceedings of the National Academy of Sciences of USA 95: 114-119 (1998), XP-002085497.
Watson et al.Molecular Biology of the Gene, 4thedition. Inside cover (1987).
Hilton et al. Twenty proteins containing a C-terminal SOCS box form five structural classes.Proc. Natl Acad Sci USA 95:114-119 (1998).

Affiliated with

Also associated with

Rating

Therapeutic and diagnostic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic and diagnostic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic and diagnostic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3881086